GlassScriptPhysician profile
Jeffrey M Zapinsky
NPI 1366537144
$6,586.79
in general payments reported to CMS, 2019-2025
42 companies · $1,535 in 2025
The $1,535 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $666 · 2020: $242 · 2021: $1,167 · 2022: $1,078 · 2023: $904 · 2024: $994 · 2025: $1,535.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,434.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,433.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $821.47 | 2019-2025 | Myrbetriq, Xtandi, Padcev |
| Sumitomo Pharma America, INC. | $736.18 | 2023-2025 | Gemtesa, Orgovyx |
| Antares Pharma, INC. | $709.31 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Dendreon Pharmaceuticals LLC | $532.23 | 2019-2025 | Provenge |
| Janssen Biotech, INC. | $412.41 | 2019-2025 | Erleada |
| Boston Scientific Corporation | $355.48 | 2020-2025 | Moses, Rezum Generator, General - Erectile Dysfunction |
| Urogen Pharma, INC. | $331.19 | 2021-2025 | Jelmyto |
| Endo Pharmaceuticals INC. | $266.73 | 2019-2022 | |
| Telix Pharmaceuticals | $240.18 | 2024-2025 | Illuccix |
| Bayer Healthcare Pharmaceuticals INC. | $177.75 | 2020-2025 | |
| Pfizer INC. | $164.54 | 2019-2025 | |
| Medtronic, INC. | $161.67 | 2025 | Interstim |
| Accord Healthcare, INC. | $152.35 | 2023-2025 | |
| 180 Medical, INC. | $138.44 | 2020-2025 | Gentlecath Glide |
| Myriad Genetic Laboratories, INC. | $129.97 | 2021-2025 | Prolaris |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urovant Sciences INC | $128.90 | 2021-2022 | |
| Coloplast Corp | $122.29 | 2021-2023 | Speedicath |
| Melinta Therapeutics, LLC | $105.98 | 2023 | Vabomere |
| Abbvie INC. | $73.72 | 2023-2024 | Botox |
| Myovant Sciences INC. | $72.14 | 2021-2022 | |
| Blue Earth Diagnostics | $71.08 | 2019-2022 | |
| Endo USA, INC. | $63.94 | 2024 | Xiaflex |
| Merck Sharp & Dohme LLC | $61.55 | 2020-2024 | Keytruda, Welireg |
| Tolmar Pharmaceuticals, INC. | $59.66 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $53.18 | 2025 | Lynparza |
| Teleflex LLC | $47.35 | 2024-2025 | Barrigel |
| Axonics, INC. | $45.46 | 2021-2024 | Bulkamid, Axonics |
| Alnylam Pharmaceuticals INC. | $44.27 | 2021 | |
| Amgen INC. | $42.93 | 2019-2021 | |
| Calyxo, INC. | $34.52 | 2025 | Cvac Aspiration System |
| Genzyme Corporation | $28.55 | 2021 | |
| Novartis Pharmaceuticals Corporation | $22.50 | 2025 | |
| Immunitybio, INC. | $20.81 | 2025 | |
| Aytu Biopharma, INC. | $20.77 | 2020 | |
| Procept Biorobotics Corporation | $19.85 | 2024 | Aquabeam System |
| Halozyme INC | $19.60 | 2023 | |
| Avadel Specialty Pharmaceuticals, LLC | $18.81 | 2019 | |
| Allergan, INC. | $18.49 | 2021 | |
| Abc Home Medical Supply, INC. | $16.64 | 2025 | |
| C. R. Bard, INC. & Subsidiaries | $15.73 | 2019 | |
| Srs Medical Systems, INC. | $15.65 | 2019 | |
| Laborie Medical Technologies Corp. | $12.52 | 2025 | Optilume Urethral Drug Coated Balloon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Zapinsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.